US Patent Issued to H. Lee Moffitt Cancer Center and Research Institute on Oct. 27 for "Immune gene signatures in cancer" (Florida, Pennsylvania Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,496, issued on Oct. 27, was assigned to H. Lee Moffitt Cancer Center and Research Institute Inc. (Tampa, Fla.).

"Immune gene signatures in cancer" was invented by James J. Mule (Odessa, Fla.), Domenico Coppola (Tampa, Fla.), Timothy J. Yeatman (Thonotosassa, Fla.), Andrey Loboda (Philadelphia) and Michael V. Nebozhyn (Yeadon, Pa.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This invention relates to methods for selecting a treatment, treating, and predicting survival time in subjects with cancer, such as colorectal cancer, based on tumor expression levels of chemokines, cytotoxic genes, and/or dendritic cell genes."

The patent was filed on May 25...